Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 1935-1942

  Sastry, Konduru S R ^a   Too, Chien Tei ^b   Kaur, Kaval ^a   Gehring, Adam J ^a   Low, Lionel ^a   Javiad, Alia ^c   Pollicino, Teresa ^d   Li, Li ^c   Kennedy, Patrick T F ^c   Lopatin, Uri ^e   Macary, Paul A ^b   Bertoletti, Antonio ^a,f,g  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF MESSINA   (Italy)

^e ROCHE BIOSCIENCE   (United States)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA 2 MICROGLOBULIN; ENV 183-91 PROTEIN HLA A2 COMPLEX; EPITOPE; FREUND ADJUVANT; HLA A2 ANTIGEN; HLA ANTIBODY; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GENOTYPE; HEAVY CHAIN; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN PRESENTATION; CELL LINE; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICE; RECEPTORS, ANTIGEN, T-CELL; VIRAL ENVELOPE PROTEINS;

HEPATITIS B VIRUS;

EID: 79551697736     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01990-10     Document Type: Article

References (18)

1. Bjorkman, P. J., et al. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512. (Pubitemid 17131093)
2. Cohen, C. J., et al. 2002. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Res. 62:5835-5844. (Pubitemid 35204743)
3. Cohen, C. J., et al. 2003. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies. J. Immunol. 170:4349-4361. (Pubitemid 36428205)
4. Dadaglio, G., C. A. Nelson, M. B. Deck, S. J. Petzold, and E. R. Unanue. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6:727-738.
5. Dubowchik, G., and M. Walker. 1999. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. Pharmacol. Ther. 83:67-123.
6. Engberg, J., M. Krogsgaard, and L. Fugger. 1999. Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy. Immunotechnology 4:273-278. (Pubitemid 29170035)
7. Ganem, D., and H. Varmus. 1987. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:651-693.
8. Gehring, A. J., et al. 2007. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J. Virol. 81:2940-2949. (Pubitemid 46447057)
9. Jaroszewicz, J., et al. 2010. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J. Hepatol. 52:514-522.
10. Kohler, G., and C. Milstein. 1975. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
11. Matsui, K., et al. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788-1791. (Pubitemid 21917527)
12. Nayersina, R., et al. 1993. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
13. Norder, H., A. M. Courouce, and L. O. Magnius. 1994. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198:489-503.
14. Porgador, A., J. W. Yewdell, Y. Deng, J. W. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class 1 complexes using a monoclonal antibody. Immunity 6:715-726.
15. Shin, E. C., et al. 2006. Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J. Clin. Invest. 116:3006-3014.
16. Sun, D., and M. Nassal. 2006. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J. Hepatol. 45:636-645. (Pubitemid 44466664)
17. Tan, A. T., et al. 2008. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J. Virol. 82:10986-10997.
18. Yewdell, J. W. 2006. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25:533-543. (Pubitemid 44529047)